This is a $5,281,381.50 firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to the J. Craig Venter Institute, Inc. (JCVI), a non-profit genomics research organization, for the rapid synthesis of plasmids and mutagenesis. The contract has an ultimate completion date of September 29, 2028. This contract is not set aside for any specific business category. JCVI is a leading genomics research institution that has received numerous awards from federal agencies, including the NIH, NSF, Department of Defense, and NASA, for its work in areas such as genomics, bioinformatics, synthetic biology, and infectious disease research. The institute's expertise and capabilities in molecular biology techniques and space-related biomedical research have made it a valuable partner for government agencies in advancing scientific research and development.
Generated 12/4/24, 9:30 AM